Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Has Made The -14.41% Recovery, Could Gain Another -3276.27% Ahead

In recent trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 0.49 million shares changing hands at last check today with its beta currently measuring 0.25. Company’s recent per share price level of $1.18 trading at -$0.27 or -18.28% at last check today assigns it a market valuation of $26.39M. That most recent trading price of CYCC’s stock is at a discount of -3276.27% from its 52-week high price of $39.84 and is indicating a discount of -14.41% from its 52-week low price of $1.35.

For Cyclacel Pharmaceuticals Inc (CYCC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) trade information

Cyclacel Pharmaceuticals Inc’s shares saw a change of -80.30% in year-to-date performance and have moved -25.94% in past 5-day. Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) showed a performance of -79.08% in past 30-days.

Wall Street analysts have assigned a consensus price target of 1 to the stock, which implies a fall of -18.0% to its recent value today. Analysts have been projecting 1 as a low price target for the stock while placing it at a high target of 1. It follows that stock’s current price would jump 15.25% in reaching the projected high whereas dropping to the targeted low would mean a gain of 15.25% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 57.31% during past 5 years.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 3.24 shares of worth $3662.0 or 0.01% of the total outstanding shares. The later fund manager was in possession of 653.0 shares on Mar 31, 2025 , making its stake of worth around $738.0 in the company or a holder of 0.00% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.